Sort
261,768 grants matching “gene therapy”
Preclinical development of AlaTIMP-2 as an cancer therapeutic
$964,392William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Targeting MMP9 to Improve Outcomes in Serious Influenza Infections
$964,377Kevin S Harrod · University Of Alabama At Birmingham · R01 · FY2016 · AI
Human and mouse transcriptome profiling identifies cross-species homology of mononuclear phagocytes
$964,320Claudia V Jakubzick · Dartmouth College · R35 · FY2024 · HL
Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity
$964,277Brian D Brown · Icahn School Of Medicine At Mount Sinai · U01 · FY2024 · CA
Validation of the Genetically Malleable Oncopig Hepatocellular carcinoma (HCC) Model for Targeted Therapeutic Development
$964,276Kyle Schachtschneider · Sus Clinicals, Inc. · R44 · FY2023 · CA
Metabolic control of normal and malignant hematopoiesis
$964,128Andrew Michael Intlekofer · Sloan-Kettering Inst Can Research · R37 · FY2025 · CA
The Laboratory of Stem Cell Biology
$964,085Mahendra Rao · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2013 · AR
Genome Instability in Cancer Development
$963,810Kyungjae Myung · National Human Genome Research Institute · ZIA · FY2012 · HG
RECOMBINANT AAV FOR CORRECTION OF GENETIC ABNORMALITIES
$963,786University Of Florida · P01 · FY2001 · DK
Single-Cell Transcriptomics of Non-Activated Latently Infected T cells Isolated from HIV+ Drug Users
$963,778Melanie Maria Ott · J. David Gladstone Institutes · R33 · FY2022 · DA
Longitudinal Assessment of Manic Symptoms
$963,751Robert L Findling · Johns Hopkins University · R01 · FY2014 · MH
Gene Regulation as a Foundation for Autoimmune Disease Prevention
$963,738Matthew Tyson Weirauch · Cincinnati Childrens Hosp Med Ctr · U01 · FY2021 · AI
Fruit exosome-like particles for therapeutic delivery of extracellular miRNAs
$963,705Huang-Ge Zhang · University Of Louisville · UH3 · FY2016 · TR
Development and implementation of multiplex methods to understand the biology and heterogeneity of patient-derived cancer models
$963,693William C Hahn · Dana-Farber Cancer Inst · U01 · FY2022 · CA
Treatments Against RA and Effect on FDG PET CT: The TARGET TRIAL
$963,561Daniel Hal Solomon · Brigham And Women'S Hospital · U01 · FY2015 · AR
Role of Memory T Cell Dynamics in SIV Infection
$963,517Louis J. Picker · Oregon Health & Science University · R37 · FY2015 · AI
Development of GEM and GDA models of Pancreatic Adenocarcinoma
$963,457Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research
$963,452Xihong Lin · Harvard School Of Public Health · R35 · FY2015 · CA
India International Center for Excellence in Research
$963,448Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Targeting the MYC Pathway for the Treatment of Cancer
$963,300Dean W Felsher · Stanford University · R35 · FY2021 · CA
Cerebrospinal Fluid in PASC: A Window into the COVID Mind
$963,211Serena S Spudich · Yale University · R01 · FY2023 · MH
Integrative Resource to Develop Translational Strategies to Promote Longevity
$963,198Steven R Cummings · California Pacific Med Ctr Res Institute · U24 · FY2017 · AG
Development and implementation of multiplex methods to understand the biology and heterogeneity of patient-derived cancer models
$963,150William C Hahn · Dana-Farber Cancer Inst · U01 · FY2021 · CA
Molecular Drivers of Atherosclerosis in Diabetes
$962,975Mete Civelek · University Of Virginia · U01 · FY2024 · DK
Reversing Cellular immortality in cancer
$962,915Steven E Artandi · Stanford University · R35 · FY2020 · CA